SCHEMBL16523045

SCHEMBL16523045

CCC(C)CCCc1ccc(CO)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
ESR1 P03372 2/20 0.37
ADRA2A P08913 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
TACR2 P21452 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
SHBG P04278 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
HSPD1 P10809 1/20 0.37
ADRB3 P13945 1/20 0.37
HTR2C P28335 1/20 0.37
HSPE1 P61604 1/20 0.37
HIF1A Q16665 1/20 0.37
TST Q16762 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL105717 0.85 ESR1 (0.55) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL28350462 0.82 CYP1A2 (0.43)
SCHEMBL27757380 0.81 TAAR1 (0.42) ALDH1A1KDM4EPTGS1PTGS2
SCHEMBL10605113 0.81 MAOB (0.48) ALDH1A1CYP3A4
SCHEMBL21131657 0.81 PPARA (0.44) SLC6A2SLC6A3
SCHEMBL9766520 0.81 ESR1 (0.33) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL107901 0.80 SIGMAR1 (0.47) ADRA2ASLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL9766497 0.79 FDFT1 (0.34) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL27537018 0.79 ESR1 (0.58) ALDH1A1ESR1ADRA2AADORA3TACR2
SCHEMBL10806880 0.78 ESR1 (0.61) ALDH1A1ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150057261-A1 AZETIDINE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS ALLERGAN, INC. 2015-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057261-A1 AZETIDINE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS S1PR1, S1PR2, S1PR5 ALDH1A1 3129/4885ESR1 2097/4885ADRA2A 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.